EchoGo Pro vs cvi42 Auto Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoGo Pro

by Ultromics

cvi42 Auto Imaging

by Circle Cardiovascular Imaging Inc.

AI Verdict

While both tools leverage AI to enhance cardiac diagnosis, EchoGo Pro specifically automates stress echocardiography analysis for coronary artery disease via a cloud-based solution. In contrast, cvi42 Auto Imaging offers comprehensive AI-powered analysis for cardiovascular MR and CT images, typically deployed on-premise, covering a broader range of cardiac and vascular conditions. Their distinct primary imaging modalities and deployment strategies make them suitable for different clinical workflows and IT infrastructures.

Choose EchoGo Pro if…

Choose EchoGo Pro if your primary need is rapid, AI-powered automation of stress echocardiography analysis specifically for the diagnosis of coronary artery disease. This cloud-based solution provides near-instant, accurate reports, making it ideal for high-volume clinics seeking to streamline workflows and improve diagnostic accuracy in stress echo interpretation.

View EchoGo Pro →

Choose cvi42 Auto Imaging if…

Choose cvi42 Auto Imaging if your clinical practice requires comprehensive, multi-modality analysis of both cardiovascular MR and CT images, including detailed plaque quantification and advanced functional assessment. This AI-powered software is well-suited for institutions needing in-depth quantitative analysis, 3D visualization, and potentially on-premise deployment for granular control over diverse cardiac and vascular imaging data.

View cvi42 Auto Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoGo Pro	cvi42 Auto Imaging
Pricing	Contact vendor for pricing	Starts at $5000 per license
Deployment	Cloud-based	On-premise (standalone workstation or client/server)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro (Tool A) offers superior usability due to its cloud-based SaaS model, which eliminates the need for software installation and extensive training. This approach simplifies deployment and integration into existing clinical workflows, providing near-instant reports for enhanced efficiency. In contrast, cvi42 Auto Imaging (Tool B) relies on an on-premise deployment, which typically involves more complex setup and IT management.

Clinical Value

cvi42 Auto Imaging

While both tools are FDA-cleared and provide significant clinical value, cvi42 Auto Imaging (Tool B) offers broader and more comprehensive diagnostic capabilities. It supports multi-modality analysis (MR and CT) and includes advanced features like plaque quantification, providing deeper insights beyond the stress echocardiography analysis for coronary artery disease offered by EchoGo Pro (Tool A).

Pricing & Value

EchoGo Pro

EchoGo Pro (Tool A) provides a clearer value proposition by explicitly mentioning the availability of reimbursement codes for related products (e.g., CPT 0932T, NTAP XXE2X19). This transparency regarding potential cost recovery is a critical factor for healthcare institutions. cvi42 Auto Imaging (Tool B) states its pricing is complex due to modularity, which, while offering flexibility, lacks the immediate financial clarity of Tool A.

Enterprise Readiness

EchoGo Pro

EchoGo Pro (Tool A) demonstrates stronger enterprise readiness with its explicit statements of HIPAA compliance and BAA availability, coupled with its cloud-based SaaS deployment. Its vendor-neutrality and seamless integration with PACS/DICOM/HL7 further enhance its fit for modern healthcare IT environments. cvi42 Auto Imaging (Tool B) has less explicit compliance statements and emphasizes on-premise deployment, which may require more extensive enterprise-level integration and security considerations.

Innovation

cvi42 Auto Imaging

cvi42 Auto Imaging (Tool B) shows greater innovation through its multi-modality support for both MR and CT imaging, along with advanced quantitative analysis capabilities, including plaque quantification. This comprehensive approach to cardiovascular imaging analysis offers a more holistic and detailed diagnostic picture. EchoGo Pro (Tool A), while innovative in automating stress echo analysis, focuses on a more specific diagnostic area.

Support & Docs

Tie

Neither the provided structured facts nor general web searches yielded specific, comparative details regarding the depth, accessibility, or quality of support and documentation for either product. Both companies likely offer standard commercial support, but without further information, a definitive winner cannot be determined in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoGo Pro	cvi42 Auto Imaging
Product Name	EchoGo Pro	cvi42 Auto Imaging
Company	Ultromics	Circle Cardiovascular Imaging
Primary Modality/Imaging Type	Stress echocardiography analysis	Cardiovascular MR and CT images
Key Automated Function	AI-powered automated echocardiogram analysis, Automated identification of coronary artery disease (CAD)	AI-enabled automated contouring and segmentation, Quantitative analysis (volume, mass, function, signal intensity, plaque)
Supported Specialties	Cardiology	Cardiology, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring EchoGo Pro and cvi42 Auto Imaging.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities do EchoGo Pro and cvi42 Auto Imaging analyze?

EchoGo Pro is an AI-powered cloud solution specifically designed to automate stress echocardiography analysis for diagnosing coronary artery disease. In contrast, cvi42 Auto Imaging is an AI-powered software that provides comprehensive analysis of cardiovascular MR and CT images, including cardiac MR, cardiac CT, and vascular CT.

What are the primary clinical applications and diagnostic capabilities of each tool?

EchoGo Pro focuses on improving the diagnosis of coronary artery disease by providing near-instant, accurate reports from automated stress echocardiography analysis. cvi42 Auto Imaging offers comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows, including cardiac function, flow, tissue characterization, and vascular assessment.

Are there specific reimbursement codes available for using these tools?

For EchoGo Pro, reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure and NTAP XXE2X19 for inpatient settings. For cvi42 Auto Imaging, a new permanent Category I CPT code 75577 for AI-enabled coronary plaque analysis became effective January 1, 2026, with major insurance companies providing coverage.

How do these tools integrate into existing clinical workflows and IT infrastructure?

EchoGo Pro is a vendor-neutral, cloud-based service that integrates seamlessly with existing clinical workflows using DICOM and HL7, requiring no software installation or extensive training. cvi42 Auto Imaging is also vendor-neutral and supports multi-modality imaging, integrating into hospital, private practice, or medical research environments, with its AI processing occurring locally within the customer's secure environment.

What is the primary focus of AI automation for each tool?

EchoGo Pro utilizes AI to automate stress echocardiography analysis, providing near-instant, comprehensive reports for the identification of coronary artery disease. cvi42 Auto Imaging employs AI for automated contouring and segmentation, enabling quantitative analysis across cardiac MR and CT scans for various metrics like chamber volumes, ejection fraction, and plaque quantification.